Want to know if you can trade Neuralink stock? Stay tuned for a full breakdown of the company and a list of competitor stocks to keep an eye on.
One of the most impressive innovators of our time might be Elon Musk.
However, he has diversified even further, with other companies under his umbrella, including Neuralink.
Neuralink has its sights set on implantable brain–machine interfaces to redefine the way we interact with technology as well as each other.
This revolutionary tech has the potential to reshape our everyday lives, which is why investors want a piece of the action.
But can you invest in Neuralink?
Read along to find out if you can invest in Neuralink and see our picks for best competitor stocks.
Some of the most impressive feats in technology we’ve had in recent years have been innovations in artificial intelligence (AI).
AI is reshaping advanced computer systems and technology networks.
As machine learning continues to develop, scientists are looking for new ways to integrate it into our lives — even in our bodies — or more precisely, our brains.
How are they going to do this, though?
Implanted brain-machine interfaces.
For instance, the Neuralink Corporation is looking to create a brain chip that will make the human brain competitive with computers through applications in AI.
Neuralink was founded in 2016 in San Francisco.
Elon Musk, along with several other partners, started the company to treat serious neurological diseases.
Its future ventures will likely include the enhancement of human brains through biologically integrated technologies.
Since the start-up of Neuralink, the company has employed several neuroscientists, chemists, and robotics engineers.
Research and development have been put into the instruments required to connect humans directly to sophisticated tech; however, they have yet to be implemented.
While most people feel that this is an impossible feat, the idea itself is something that Elon Musk and partners believe in.
Creating a symbiotic relationship between people’s brains and artificial intelligence is appealing to many, which is why the company has had several rounds of funding.
Those rounds of funding have led to large investments from many venture capital firms from around the world.
Among the investors are Valor Equity Partners, Craft Ventures, DFJ Growth, and Dreamers VC.
At this time, the company is still researching and developing the probes, robotics, and other technology required to tackle some of its goals.
In 2021, clinical trials for animals began.
In one interesting example, Neuralink demonstrated the technology in action.
A chimpanzee was shown playing the video game Pong using the Neuralink implant device.
With things moving forward for the company, there’s a chance that clinical trials are on the horizon.
This implementation will likely involve small steps, though, as integrating the tech directly at such an early stage could be dicey.
The company itself shares real estate with Elon Musk’s AI company, as well, so the two are likely working together to accelerate advancements.
Ready to build your portfolio? With Public.com you can follow other investors, discover companies that are inline with your beliefs, and invest into stocks and crypto with very little money! What are you waiting for? Check out Public Now!
At this time, Neuralink stock cannot be purchased on the stock market.
This also means that there’s no Neuralink stock symbol or Neuralink stock ticker available either.
The company is privately held, and this doesn’t look to be changing anytime soon.
However, if the company ever goes public, Neuralink stock price could be considerably high, as it already has its foothold in such a transformational technology.
It doesn’t matter if you have $500 or $5 million.
Here’s what I recommend you do with your money right now.
ATTENTION: The following video is a serious financial warning from one of America’s richest men. He believes this event will make the rich even richer while financially affecting countless others and fan the flames of social protest.
It’s free to watch and by doing so I believe you’ll be ahead of everyone else struggling to understand what is really going on. I hope you take advantage of this opportunity!
We’ll need to wait for a Neuralink stock IPO to find out, though.
Elon Musk is the owner of Neuralink.
Neuralink could be his next successful endeavor, but only time will tell.
Neuralink has the potential to be successful, as the company is pioneering an entire field of research and technology.
While other companies have shown progress regarding neural signals, none have dedicated as much time or resources to neurological integrations.
When the brain and artificial intelligence meet, it’s sure to pique investor interest.
Simply put, Neuralink is the first company to exist in its market, and it could be positioned to profit based on that alone.
To give an example of the company’s success, its current valuation is at $1 billion.
That’s impressive for a company that’s hardly 5 years old and has yet to push out a product.
If Neuralink goes public, it could be a wise idea to invest in the company.
At this time, there are no other companies with the same amount of resources available to innovate in this field.
If Neuralink can deliver on its vision, its share price could be remarkably high, assuming it’s a public company.Stock Advice That Beats The Market! Stock Advisor's recommendations have beaten the market over the past 19 years. Tired of picking losers? Stock Dork readers can join for only $99 a year! Check out Stock Advisor today!
While you can’t buy shares of Neuralink at this time, there’s a silver lining.
There are other companies that tap into some of the same tech, but they aren’t an all-in-one package like Neuralink.
Here are some competitor stocks on the market that you can invest in.
- Biogen, Inc. (NASDAQ: BIIB)
- Amgen, Inc. (NASDAQ: AMGN)
- NVIDIA Corporation (NASDAQ: NVDA)
Biogen, Inc. (NASDAQ: BIIB)
Biogen is another large company that’s working towards resolving neurological diseases for patients.
While the company isn’t creating brain-machine interfaces, it’s still making strides in neurological treatment.
This is what Neuralink aims to do in the short term.
Biogen was founded in 1978 and has been recently working towards Alzheimer’s therapies for patients.
The company has patented one such drug, and it has been used to treat patients in the U.S.
The drug helps to reduce the plaques in the brain that cause serious issues in those suffering from Alzheimer’s.
In 2020, data released by the company indicated that it made $13.4 billion.
Amgen, Inc. (NASDAQ: AMGN)
Amgen is a biopharmaceutical company located in California that was founded in 1980.
The company itself has made breakthroughs in molecular biology and chemistry.
At this time, Amgen’s goal is to provide healthcare based on recombinant DNA technology.
As of 2017, the company employed over 5,100 people.
This makes them the largest employer in Ventura County, California.
What’s more, is that it’s one of the largest independent biotechnology companies in the world.
In 2020, the company saw over $25 billion in revenue, which was up from years prior.
Amgen continues to make breakthroughs and continues to help people suffering from lifelong diseases.
NVIDIA Corporation (NASDAQ: NVDA)
If you’re looking to invest in artificial intelligence rather than medical sciences, you can’t go wrong with NVIDIA.
It is one of the largest technology companies in the world, serving many different markets.
Notably, it’s very popular within the gaming industry, providing GPUs and handheld gaming devices to the public.
In addition to this industry, it also produces microchips for vehicle systems.
In recent years, NVIDIA has been expanding into the artificial intelligence market, making headway in supercomputing.
Utilizing their GPUs, the company has been able to make machines capable of deep learning, assisting many companies with AI implementation.
Due to supply chain issues, NVIDIA saw a fall in revenue for 2020.
The company reported that it’d earned just over $10 billion for the year.
However, the value of their total assets increased, which is always a good sign.
Neuralink is positioning itself to be a leader in merging medical science and artificial intelligence.
Unfortunately, Neuralink stock is not currently available to the general public.
The company remains privately held and will likely remain as such until its technology becomes more mainstream.
Elon Musk is a firm believer in keeping things behind closed doors until they’re ready, as we’ve seen from his other companies.
In the meantime, there are other stocks from competitors that you can invest in.
However, these companies only touch on a space Neuralink is innovating in — they aren’t providing the whole package.
- The Smartest Way to Invest $500 Right Now: It doesn’t matter if you have $500 in savings or $5 million. See what one of America's richest men says you need to do right now.
- Motley Fool Issues: Rare "All In" Buy Alert! All In Stock Buy Signal Has Beaten The Market By 6X
- 25-Year-Old Prodigy Is America’s #1 Stock Picker: Brand-New Pick, Ticker Symbol and All -- FOR FREE
- URGENT BUY: 4 Hypergrowth Cryptos for 2021: Urgent video just released detailing a rare setup in the crypto markets that could send four cryptos soaring